[A-TOP research group/JOINT-02].
Kuroda
Tatsuhiko
T
Department of Obstetrics and Gynecology, Tokyo Women's Medical University.
Ohta
Hiroaki
H
Shiraki
Masataka
M
Miyakawa
Nobuaki
N
Hosoi
Takayuki
T
Nakamura
Toshitaka
T
Fukunaga
Masao
M
Orimo
Hajime
H
D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D002116:Calcitonin / Q000627:therapeutic use; D002762:Cholecalciferol / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D050723:Fractures, Bone / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D007564:Japan; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use; D014944:World Health Organization
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D020845:Selective Estrogen Receptor Modulators; D002762:Cholecalciferol; D002116:Calcitonin